HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

monoclonal antibody Ber-EP4

a commercially-available MAb generated by immunizing mice with cells from the MCF-7 breast carcinoma cell line; distinguishes epithelial mesothelioma from adenocarcinoma
Also Known As:
MAb BerEP4
Networked: 22 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Sellheyer, Klaus: 2 articles (04/2008 - 10/2007)
2. Krahl, Dieter: 2 articles (04/2008 - 10/2007)
3. Füzesi, L: 2 articles (01/2008 - 11/2005)
4. Werner, C: 2 articles (01/2008 - 11/2005)
5. Horstmann, O: 2 articles (01/2008 - 11/2005)
6. Milsmann, C: 2 articles (01/2008 - 11/2005)
7. Becker, H: 2 articles (01/2008 - 11/2005)
8. Izbicki, J R: 2 articles (04/2001 - 12/2000)
9. Scheunemann, P: 2 articles (04/2001 - 12/2000)
10. Stoecklein, Nikolas H: 1 article (01/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Carcinoma (Carcinomatosis)
3. Basal Cell Carcinoma (Rodent Ulcer)
4. Squamous Cell Carcinoma (Epidermoid Carcinoma)
5. Lung Neoplasms (Lung Cancer)

Related Drugs and Biologics

1. tumor-associated antigen GA733
2. CD34 Antigens (CD34 Antigen)
3. Complementary DNA (cDNA)
4. Vimentin
5. Paraffin
6. Oligonucleotides
7. Glycoproteins (Glycoprotein)
8. Carcinoembryonic Antigen
9. Antibodies
10. Alkaline Phosphatase

Related Therapies and Procedures

1. Adjuvant Chemotherapy
2. Immunotherapy